Scholars Central

OpinionPublished 28 Dec 2024

Understanding the Diagnostic Potential of Epitranscriptomic Changes in Cancer

Authors: Lin Cheng

Journal of Molecular Biomarkers & Diagnosis

Volume 15 · Issue 6 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Epitranscriptomics, the study of RNA modifications, has emerged as a promising field in cancer research due to its potential to reveal novel molecular mechanisms underlying tumorigenesis and progression. These RNA modifications, including methylation, pseudouridination, and acetylation, are crucial for regulating RNA stability, splicing, translation, and decay. In cancer, alterations in the epitranscriptome have been linked to various hallmarks of cancer, such as uncontrolled cell proliferation, evasion of apoptosis, and metastasis. Unlike genetic mutations that alter the DNA sequence, epitranscriptomic modifications represent a reversible layer of regulation that can modulate gene expression without changing the genetic code.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Biomarkers & Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Biomarkers & Diagnosis
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Lin Cheng”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels